Hoth Therapeutics, Inc. - COM NEW (HOTH)

CUSIP: 44148G204

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / COM NEW
Total 13F shares
304,176
Share change
+60,497
Total reported value
$303,734
Price per share
$1.00
Number of holders
16
Value change
+$61,202
Number of buys
9
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 44148G204?
CUSIP 44148G204 identifies HOTH - Hoth Therapeutics, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Hoth Therapeutics, Inc. - COM NEW (HOTH) as of Q1 2025

As of 31 Mar 2025, Hoth Therapeutics, Inc. - COM NEW (HOTH) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 304,176 shares. The largest 10 holders included GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, VANGUARD GROUP INC, Virtu Financial LLC, TWO SIGMA SECURITIES, LLC, Foundations Investment Advisors, LLC, HRT FINANCIAL LP, TWO SIGMA INVESTMENTS, LP, MORGAN STANLEY, and OSAIC HOLDINGS, INC.. This page lists 16 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.